Yi Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yi Zheng has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Songmei Geng
Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
6 shared publications - Xinyue Zhang
Xi'an Jiaotong University Second Affiliated Hospital
3 shared publications Bin Peng
Department of Dermatology, Northwest Hospital The Second Hospital Affiliated to Xi'an Jiaotong University China
2 shared publicationsDelu Che
Department of Dermatology, Northwest Hospital The Second Hospital Affiliated to Xi'an Jiaotong University China
2 shared publications- Delu Che
Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated to Xi'an Jiaotong University, Xi'an, China; Center for Dermatology Disease, Precision Medical Institute, Xi'an, China
2 shared publications - Tong Zhou
Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated to Xi'an Jiaotong University, Xi'an, China
2 shared publications
Latest Publications
- Open Access
- 14 January 2026
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 21 (1) , 17
Assessment of Ten Insulin Resistance Surrogate Indexes Predicts New-Onset Cardiovascular Disease Incidence in Patients with Prediabetes or Diabetes: Insights from CHARLS Data with Machine Learning Analysis
Objective: Insulin resistance (IR) is a key driver of prediabetes, type 2 diabetes, and cardiovascular disease (CVD) risk. This study evaluated the predictive performance of ten IR surrogate indexes (TyG, TyG-BMI, TyG-WC, TyG-WHtR, METS-IR, AIP, TyHGB, CTI, eGDR, CVAI) for new-onset CVD in Chinese patients with prediabetes or diabetes, aiming to identify the most effective index for cardiovascular risk stratification. Methods: This longitudinal cohort study analyzed 3,532 middle-aged and elderly participants from the China Health and Retirement Longitudinal Study (CHARLS) baseline (Wave 1), with incident CVD events assessed at follow-up (Wave 4). Ten IR surrogate indexes were calculated at baseline. Multivariate logistic regression, adjusted for confounders, assessed associations between these indexes and CVD. Non-linear relationships were explored using restricted cubic spline analyses. Nine machine learning algorithms were employed to develop predictive models, with performance evaluated via receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis. Results: During follow-up, 874 participants (24.7%) developed CVD. Each standard deviation increase in eGDR was associated with reduced CVD risk (OR = 0.822, 95% CI: 0.696–0.969), while CVAI was linked to increased risk (OR = 1.124, 95% CI: 1.028–1.229). Compared to the lowest quartile, the highest eGDR quartile had a 47.3% lower CVD risk (OR = 0.527, 95% CI: 0.353–0.789, P = 0.0018), and the highest CVAI quartile had a 33.1% higher risk (OR = 1.331, 95% CI: 1.038–1.709, P = 0.0243). Incorporating eGDR and CVAI into machine learning models, particularly K-Nearest Neighbors (KNN), enhanced discrimination (AUC = 0.936, 95% CI: 0.928–0.943). Conclusion: eGDR and CVAI outperformed other IR indexes in predicting CVD in Chinese patients with prediabetes or diabetes. Their integration into KNN models significantly improved risk stratification, suggesting their utility as accessible clinical tools for early identification and intervention to reduce CVD burden.
- 14 January 2026
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 21 (1) , 17
Open AccessAssessment of Ten Insulin Resistance Surrogate Indexes Predicts New-Onset Cardiovascular Disease Incidence in Patients with Prediabetes or Diabetes: Insights from CHARLS Data with Machine Learning Analysis
Objective: Insulin resistance (IR) is a key driver of prediabetes, type 2 diabetes, and cardiovascular disease (CVD) risk. This study evaluated the predictive performance of ten IR surrogate indexes (TyG, TyG-BMI, TyG-WC, TyG-WHtR, METS-IR, AIP, TyHGB, CTI, eGDR, CVAI) for new-onset CVD in Chinese patients with prediabetes or diabetes, aiming to identify the most effective index for cardiovascular risk stratification. Methods: This longitudinal cohort study analyzed 3,532 middle-aged and elderly participants from the China Health and Retirement Longitudinal Study (CHARLS) baseline (Wave 1), with incident CVD events assessed at follow-up (Wave 4). Ten IR surrogate indexes were calculated at baseline. Multivariate logistic regression, adjusted for confounders, assessed associations between these indexes and CVD. Non-linear relationships were explored using restricted cubic spline analyses. Nine machine learning algorithms were employed to develop predictive models, with performance evaluated via receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis. Results: During follow-up, 874 participants (24.7%) developed CVD. Each standard deviation increase in eGDR was associated with reduced CVD risk (OR = 0.822, 95% CI: 0.696–0.969), while CVAI was linked to increased risk (OR = 1.124, 95% CI: 1.028–1.229). Compared to the lowest quartile, the highest eGDR quartile had a 47.3% lower CVD risk (OR = 0.527, 95% CI: 0.353–0.789, P = 0.0018), and the highest CVAI quartile had a 33.1% higher risk (OR = 1.331, 95% CI: 1.038–1.709, P = 0.0243). Incorporating eGDR and CVAI into machine learning models, particularly K-Nearest Neighbors (KNN), enhanced discrimination (AUC = 0.936, 95% CI: 0.928–0.943). Conclusion: eGDR and CVAI outperformed other IR indexes in predicting CVD in Chinese patients with prediabetes or diabetes. Their integration into KNN models significantly improved risk stratification, suggesting their utility as accessible clinical tools for early identification and intervention to reduce CVD burden.
- 21 July 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (1) , 53-62.e2
Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis
- 21 July 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (1) , 53-62.e2
Mast Cells Initiate Type 2 Inflammation through Tryptase Released by MRGPRX2/MRGPRB2 Activation in Atopic Dermatitis
- 19 December 2022
- Published by Wiley in Experimental Dermatology
- Vol. 32 (4) , 436-446
Hydroquinone‐induced skin irritant reaction could be achieved by activating mast cells via mas‐related G protein–coupled receptor X2
Hydroquinone (HQ) is one of the most effective drugs to treat hyperpigmentary disorders, but often causes skin irritation in clinic. Mast cell plays an important role in contact dermatitis and triggering pseudo‐allergic reactions via MRGPRX2. Whether HQ‐induced skin irritant reaction through activating mast cells via MRGPRX2 remains unknown. To investigate the role of mast cells in HQ‐induced skin irritant reaction and verify whether MRGPRX2 participated in the HQ effect on mast cells which contributed to the pathogenesis of skin irritant reaction, a mouse model of HQ‐induced skin irritation was established to observe the local and systemic inflammation associated with mast cell receptor MrgprB2. Human mast cell LAD2 was used to verify the effect of HQ on mast cells via MRGPRX2 by knocking down with siRNA. As a result, mast cells were involved in the development of HQ‐induced irritant reaction, and local inflammation is closely related to mast cell receptor MrgprB2. HQ could activate mast cells via MRGPRX2, causing changes in calcium concentration, degranulation and release of inflammatory cytokines which lead to skin irritant reaction. In conclusion, HQ‐induced skin irritant reaction could be skin pseudo‐allergic reactions achieved by activating mast cells via MRGPRX2.
- 19 December 2022
- Published by Wiley in Experimental Dermatology
- Vol. 32 (4) , 436-446
Hydroquinone‐induced skin irritant reaction could be achieved by activating mast cells via mas‐related G protein–coupled receptor X2
Hydroquinone (HQ) is one of the most effective drugs to treat hyperpigmentary disorders, but often causes skin irritation in clinic. Mast cell plays an important role in contact dermatitis and triggering pseudo‐allergic reactions via MRGPRX2. Whether HQ‐induced skin irritant reaction through activating mast cells via MRGPRX2 remains unknown. To investigate the role of mast cells in HQ‐induced skin irritant reaction and verify whether MRGPRX2 participated in the HQ effect on mast cells which contributed to the pathogenesis of skin irritant reaction, a mouse model of HQ‐induced skin irritation was established to observe the local and systemic inflammation associated with mast cell receptor MrgprB2. Human mast cell LAD2 was used to verify the effect of HQ on mast cells via MRGPRX2 by knocking down with siRNA. As a result, mast cells were involved in the development of HQ‐induced irritant reaction, and local inflammation is closely related to mast cell receptor MrgprB2. HQ could activate mast cells via MRGPRX2, causing changes in calcium concentration, degranulation and release of inflammatory cytokines which lead to skin irritant reaction. In conclusion, HQ‐induced skin irritant reaction could be skin pseudo‐allergic reactions achieved by activating mast cells via MRGPRX2.
- Open Access
- 1 July 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 95 (4) , 538-540
Apresentação rara da síndrome de Rothmund‐Thomson com novas mutações heterozigóticas compostas do gene RECQL4
- 1 July 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 95 (4) , 538-540
Open AccessApresentação rara da síndrome de Rothmund‐Thomson com novas mutações heterozigóticas compostas do gene RECQL4
- Open Access
- 1 July 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 95 (4) , 538-540
Rare presentation of Rothmund-Thomson syndrome with novel compound heterozygous mutations of the RECQL4 gene
- 1 July 2020
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 95 (4) , 538-540
Open AccessRare presentation of Rothmund-Thomson syndrome with novel compound heterozygous mutations of the RECQL4 gene
- 21 April 2019
- Published by Wiley in Contact Dermatitis
- Vol. 81 (3) , 184-193
All‐trans‐retinoic acid activated mast cells via Mas‐related G‐protein‐coupled receptor‐X2 in retinoid dermatitis
Background Retinoic acid (RA) induced dermatitis is the most frequent side effect which limits its wide use. However, the exact mechanisms triggering dermatitis is not fully understood, including the role of skin mast cells. The newly discovered MRGPRX2 in mast cells mediates pseudoallergic drug reactions in several types of dermatitis. A possible contribution of MRGPRX2 to contact dermatitis induced by RA has hitherto not been examined. Objectives To investigate whether all‐trans retinoic acid (ATRA) activates mast cells via MRGPRX2/MrgprB2(the mouse ortholog), which contribute to pathogenesis of retinoid‐induced dermatitis. Methods Wild‐type (WT) and MrgprB2‐/‐ mice were treated with topical ATRA to observe local inflammation and mast cell degranulation in vivo by Haematoxilin & Eosin and immunofluorescence staining. Release of histamine and β‐hexosaminidase were measured and calcium influx were detected in LAD2 cells with specific knockdown targeting MRGPRX2 by siRNA and primary cells from MrgprB2‐/‐ mice. Results Compared to WT mice, MrgprB2‐/‐ mice showed resistance to ATRA triggered contact dermatitis and local inflammatory reactions in paws. ATRA activated mast cells via MrgprB2 pathway in murine, and via MRGPRX2 pathway in human mast cells. Conclusions ATRA induced dermatitis could be achieved by activating mast cells via MRGPRX2/MrgprB2, which may provide the potential therapy target to reduce the side effect.
- 21 April 2019
- Published by Wiley in Contact Dermatitis
- Vol. 81 (3) , 184-193
All‐trans‐retinoic acid activated mast cells via Mas‐related G‐protein‐coupled receptor‐X2 in retinoid dermatitis
Background Retinoic acid (RA) induced dermatitis is the most frequent side effect which limits its wide use. However, the exact mechanisms triggering dermatitis is not fully understood, including the role of skin mast cells. The newly discovered MRGPRX2 in mast cells mediates pseudoallergic drug reactions in several types of dermatitis. A possible contribution of MRGPRX2 to contact dermatitis induced by RA has hitherto not been examined. Objectives To investigate whether all‐trans retinoic acid (ATRA) activates mast cells via MRGPRX2/MrgprB2(the mouse ortholog), which contribute to pathogenesis of retinoid‐induced dermatitis. Methods Wild‐type (WT) and MrgprB2‐/‐ mice were treated with topical ATRA to observe local inflammation and mast cell degranulation in vivo by Haematoxilin & Eosin and immunofluorescence staining. Release of histamine and β‐hexosaminidase were measured and calcium influx were detected in LAD2 cells with specific knockdown targeting MRGPRX2 by siRNA and primary cells from MrgprB2‐/‐ mice. Results Compared to WT mice, MrgprB2‐/‐ mice showed resistance to ATRA triggered contact dermatitis and local inflammatory reactions in paws. ATRA activated mast cells via MrgprB2 pathway in murine, and via MRGPRX2 pathway in human mast cells. Conclusions ATRA induced dermatitis could be achieved by activating mast cells via MRGPRX2/MrgprB2, which may provide the potential therapy target to reduce the side effect.